Author

Minakshi Garg

Institution: Delhi Pharmaceutical Science and Research University

Observed institutions: Rajendra Memorial National Institute of Health Research, Indian Council of Medical Research, Maulana Azad Medical College, Delhi Pharmaceutical Science and Research University

ORCID: 0000-0002-5065-0832

Observed ORCID: 0000-0002-5065-0832

OpenAlex ID: A5028298721

Formulation Strategies for Enhancing Pharmaceutical and Nutraceutical Potential of Sesamol: A Natural Phenolic Bioactive

2023 · Anroop B. Nair, Pooja Dalal, et al. · Plants · 32

A Fresh Look on Bergenin: Vision of Its Novel Drug Delivery Systems and Pharmacological Activities

2022 · Sidharth Mehta, Varsha Kadian, et al. · Future Pharmacology · 30

Formulation, Characterization, Anti-Inflammatory and Cytotoxicity Study of Sesamol-Laden Nanosponges

2022 · Anroop B. Nair, Pooja Dalal, et al. · Nanomaterials · 23

Diabetes and NAFLD: A Synergistic Threat to Metabolic Health

2025 · Shilpa Chaudhary, Keerti Manocha, et al. · Advanced Pharmaceutical Bulletin · 2

Comparative preclinical assessment of relugolix tablets and relugolix intravenous injection

2026 · Priyanka Nagar, Arvind Kumar Sharma, et al. · Scientific Reports · 1

Development and Optimization of a Stable Parenteral Formulation of Relugolix to Overcome Oral Bioavailability Limitations in the Management of Prostate Cancer

2026 · Priyanka Nagar, Robin Kumar, et al. · Journal of Pharmaceutical Innovation

Adverse Drug Reactions Associated With Longer All-Oral MDR/XDR-TB Regimens: Prospective Pharmacovigilance Evidence From a High-Burden Tertiary Care Setting in North India

2026 · Amit Kamboj, Kshitij Agarwal, et al. · Annals of Pharmacotherapy

Patterns of adverse drug reactions and treatment outcomes in drug-resistant tuberculosis: A retrospective study from a tertiary care hospital in Delhi

2025 · Amit Kamboj, Kshitij Agarwal, et al. · Perspectives in Clinical Research

Advancing relugolix analysis: A comparative study and AQbD-driven method optimization with stability testing

2025 · Priyanka Nagar, Arvind Kumar Sharma, et al. · Journal of Applied Pharmaceutical Science

Safety Surveillance of Covishield Vaccine-Associated Adverse Events During the COVID-19 Pandemic: A Retrospective Longitudinal Study

2024 · Shilpa Chaudhary, Monica Aggarwal, et al. · Cureus

Works count: 10

Citation count: 88

H-index: 3

I10-index: 3